Lundbeck is a Danish company headquartered in Copenhagen and focused entirely on brain diseases, including depression, schizophrenia, Alzheimer's and Parkinson's, with drugs such as the antidepressant Brintellix and Rexulti for schizophrenia.
Lundbeck competes with much larger US and global firms in psychiatric and neurological treatment.